StonvexLoading…
StonvexStonvexStonvexCore line items from MMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $1.38M | $562.31K | $1.54M | $940.80K |
Operating Income | $26.02M | $14.41M | $20.60M | $-11.20M |
Net Income | $-26.02M | $-14.41M | $-20.60M | $-11.20M |
EPS (Diluted) | $-1.99 | $-1.40 | $-5.26 | $-2.86 |
Total Assets | $6.77M | $5.32M | $7.23M | Not available |
Total Liabilities | $8.16M | $2.76M | $38.37M | Not available |
Cash & Equivalents | $2.08M | $3.54M | $3.70M | $569.98K |
Free Cash Flow OCF − CapEx | $-8.31M | $-9.35M | $-5.52M | $-8.11M |
Shares Outstanding | 65.00K | 65.00K | Not available | Not available |